Stockreport

Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024

Fractyl Health, Inc.  (GUTS) 
PDF Results showed single-administration GLP-1 pancreatic gene therapy candidate reduced liver weight by 42% (p Data also demonstrated reductions of 36% in total cholestero [Read more]